SECRETORY PHOSPHOLIPASE A2 (SPLA2) AS PROGNOSTIC AND DIAGNOSTIC MARKER FOR CARDIOVASCULAR DISEASES
摘要
<p>The present invention relates to a method for determining an increased risk of mortality or of a cardiac and/or vascular event in a patient, comprising: - determining the sPLA2 activity of said patient, - comparing said activity to a predetermined value, a higher sPLA2 activity of said patient as compared to said predetermined value being indicative of an increased risk of mortality or of a cardiac and/or vascular event.</p>
申请公布号
EP1769083(A2)
申请公布日期
2007.04.04
申请号
EP20050766051
申请日期
2005.07.15
申请人
I.N.S.E.R.M. INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE